Transparent Allocation
Token Distribution Architecture
Aizalea (AIZA) is engineered for long-term sustainability. Our distribution model ensures balanced ecosystem growth, prioritizing community rewards and continuous clinical AI development.
Allocation Breakdown
Total Supply: 2,000,000,000 AIZA
| Category | Percentage | Tokens (AIZA) |
|---|---|---|
Fund Raising | 20% | 400,000,000 |
Staking & Community Rewards | 20% | 400,000,000 |
Reserve & Development | 20% | 400,000,000 |
Team & Advisors | 15% | 300,000,000 |
Partnerships | 15% | 300,000,000 |
Liquidity Pool & Stability | 10% | 200,000,000 |
Growth Engine
The strategic evolution of the AizaHcare ecosystem, detailing our progression from physical infrastructure to a globally decentralized AI healthcare network powered by Aizalea.
Q1 2026
Ecosystem Consolidation & Vertical Integration
Transformation of AizaHcare into a fully vertically integrated AI healthcare infrastructure, combining medical centers, real-world patient data, AI models, sovereign compute (MAIDA), and data center capabilities to enable scalable healthcare solutions..
Q2 2026Active Phase
Ecosystem Acceleration & Strategic Partnerships
Launch of a global growth campaign supported by international ambassadors to accelerate the development of key projects, including Diabetes and Elder Care AI solutions, legal structuring of the DATS3 dermato-cosmetic line in the UAE, and official initiation of the MAIDA 50MW data center project in Morocco.
Q3 2026
Pre-Market Validation & Industrialization
Testing and validation phase of Diabetes and Elder Care AI solutions, combined with production and marketing launch of the DATS3 dermato-cosmetic line, and initiation of MAIDA data center construction.
Q4 2026
Go-To-Market & Medical Expansion
Official go-to-market of Diabetes and Elder Care AI solutions, opening of new medical centers, and Aizalea token listing to support ecosystem liquidity, accessibility, and global expansion.
2027+
Global Scale & AI Healthcare Expansion
Scaling the medical center network internationally and opening AI solution licensing to third-party healthcare providers.